Cardiosense Receives FDA De Novo Classification for Novel Cardiac Technology Designed to Improve Care for Patients with Heart Failure

Antihypertensive Use Tied to Higher Fall Risk Across Groups

Early Palliative Integration for Heart Failure

Did heart health impact the risk of severe COVID-19 infection during the pandemic?

Air Pollution Tied to Poor Valvular Heart Disease Outcomes

Common Food Additives Linked to Heart Risks

Conduction system pacing after TAVR linked to improved outcomes in new meta-analysis

Tech breakthroughs, new policies help cardiologists perform more concomitant EP procedures

J&J recalls certain heart pump controllers due to hardware issues

FDA confirms Class I recall for vascular device used by cardiologists and surgeons